Biomarkers for the development of novel disease-modifying therapies for osteoporosis. Biomarkers in Medicine. December 2008, added with permission of MHN Advisor Jingsong Wang. Keywords: rheumatology; molecular markers; magnetic resonance imaging; delayed gadolinium-enhanced MRI; translational medicine; cartilage metabolism; biosynthesis; collagen; DMOAD; FDA; European Medicines Agency

File Type: pdf
File Size: 581 KB
Categories: Health, Other health issues
Tags: biosynthesis, cartilage metabolism, collagen, delayed gadolinium-enhanced MRI, DMOAD, Fda, magnetic resonance imaging, molecular markers, rheumatology, translational medicine